Delivery Order SPE2DB25D7068-SPE2DB25FTYCG
- Not listed
- The Defense Logistics Agency awarded a $15,032.22 delivery order to AmerisourceBergen Drug Corp for Shingrix vial kits, with an ultimate completion date of April 25, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. The place of performance is listed as Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order valued at $1,139.18 to AmerisourceBergen Drug Corp for Shingrix vial kits on August 4, 2025, with completion scheduled for August 5, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The place of performance is AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $2,278.36 to AmerisourceBergen Drug Corp for Shingrix vial kits on July 16, 2025, with completion targeted for July 17, 2025. This competitively awarded, firm fixed price delivery order represents a small-value pharmaceutical procurement executed through AmerisourceBergen's existing contract vehicle with DLA. The work will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. Shingrix is a recombinant...
- The Defense Logistics Agency awarded a delivery order valued at $8,456.06 to AmerisourceBergen Drug Corp for Shingrix vial kits on August 27, 2025, with an ultimate completion date of August 28, 2025. This competitive award, executed under firm fixed pricing, represents a child order issued against AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.99 million through December 2026. The place of performance is listed as the vendor's...
- The Defense Logistics Agency awarded a $14,012.49 delivery order to AmerisourceBergen Drug Corp for Shingrix vial kits, with an ultimate completion date of August 18, 2025. This contract represents a firm fixed-price delivery order issued under a competitive procurement with no set-aside designation. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. Shingrix is a recombinant zoster vaccine used for the prevention of herpes zoster (shingles) in...
- The Defense Logistics Agency awarded a delivery order valued at $3,417.54 to AmerisourceBergen Drug Corp for Shingrix vial kits on July 28, 2025, with completion expected by July 29, 2025. The contract is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and will perform the work at its corporate office location. Shingrix is a recombinant zoster vaccine used...
- The Defense Logistics Agency awarded a delivery order valued at $10,533.22 to AmerisourceBergen Drug Corp for Shingrix vial kits on September 11, 2025, with completion scheduled for September 12, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and is being performed at the contractor's facility in Conshohocken, Pennsylvania. Shingrix is a recombinant zoster vaccine used for prevention of herpes zoster (shingles) and post-herpetic neuralgia in...
- The Defense Logistics Agency awarded a delivery order valued at $4,556.72 to AmerisourceBergen Drug Corp for Shingrix vial kits, with an ultimate completion date of August 27, 2025. This contract is a firm fixed price delivery order with no set-aside designation, issued on August 26, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a pediatric/adult immunization procurement, as Shingrix is a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Shingrix vial kits valued at $17,282.29 under a firm fixed-price contract. The award was made on August 4, 2025, with an ultimate completion date of August 5, 2025, and represents a non-competitive set-aside delivery order. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under the company's existing...
- The Defense Logistics Agency awarded a delivery order valued at $2,278.36 to AmerisourceBergen Drug Corp for Shingrix vial kits on September 2, 2025, with an ultimate completion date of September 3, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and will be performed at the contractor's location in Conshohocken, Pennsylvania. Shingrix is a recombinant zoster vaccine used for the prevention of herpes zoster (shingles) and is a critical...
- SPE2DB25D7068Indefinite Delivery Contract
- SPE2DB25D7068-SPE2DB25FTYCGDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,278.36 to AmerisourceBergen Drug Corp for Shingrix vial kits on September 19, 2025, with completion targeted for September 22, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters as a major pharmaceutical distributor serving federal medical procurement needs. Shingrix is a recombinant zoster vaccine indicated for prevention of herpes zoster and related complications in adults. This delivery order fulfills a specific requirement within AmerisourceBergen's comprehensive pharmaceutical supply agreement with the DLA, which enables the company to distribute a wide range of medications, vaccines, and medical supplies to support military healthcare programs globally. The no set-aside designation indicates this award was made through open competition, consistent with AmerisourceBergen's established track record of competitively winning federal medical supply contracts across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.3k | 9/19/25 |